Nano-Particle based thermal barriers for the stabilization of proteinaceous and pharmaceuticalcontainers

点击翻译按钮获取中文摘要

VivaVax is creating new technologies that protect sensitive medicines during transport, and formulations that enhance drug delivery into the body. The World Health Organization estimates that 50% of vaccines are wastedglobally, and up to 70% in developing regions. VivaVax will collaborate with Seneca's School of Biological Science and Applied Chemistry to reduce this number by creating next-generation thermal-barriers for vaccine containers through the development of a novel pore-generation technique within polymer films. Led byProfessor James Mayo and Professor Frank Merante, student Research Assistants (RAs) from Seneca'sBiotechnology Advanced Diploma Program will participate in this project. Improvements developed during thecourse of the project will allow the company to add product lines within its current target market in 2020.Enhancing VivaVax's technology will allow VivaVax to develop two to three new product lines within twoyears of product development.